Company research
TENET HEALTHCARE CORP
CIK 70318Updated Sep 24, 2026
SecurityTHC · NYSE · equity
Name history
NATIONAL MEDICAL ENTERPRISES INC /NV/ · through Mar 27, 1995
THC price & chart
Loading TradingView…
NYSE:THC on TradingView ↗About the company
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.
In the news
No coverage from other publishers is available.
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
144 filing
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
SCHEDULE 13G/A filing
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 29,677,000,000Source | 28,936,000,000Source | 28,312,000,000Source | 27,156,000,000Source |
| GoodwillUSD | 11,198,000,000Source | 10,691,000,000Source | 10,307,000,000Source | 10,123,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,348,000,000Source | 1,397,000,000Source | 1,368,000,000Source | 1,424,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,883,000,000Source | 3,019,000,000Source | 1,228,000,000Source | 858,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,565,000,000Source | 2,536,000,000Source | 2,914,000,000Source | 2,943,000,000Source |
| Inventory, NetUSD | 348,000,000Source | 346,000,000Source | 411,000,000Source | 405,000,000Source |
| Assets, CurrentUSD | 7,849,000,000Source | 7,682,000,000Source | 7,167,000,000Source | 5,981,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,134,000,000Source | 1,037,000,000Source | 1,083,000,000Source | 1,129,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 20,704,000,000Source | 20,389,000,000Source | 22,804,000,000Source | 22,548,000,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 8,000,000Source | 8,000,000Source | 8,000,000Source | 8,000,000Source |
| Additional Paid in CapitalUSD | 4,914,000,000Source | 4,873,000,000Source | 4,834,000,000Source | 4,778,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 4,415,000,000Source | 3,008,000,000Source | -192,000,000Source | -803,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -181,000,000Source | -180,000,000Source | -181,000,000Source | -181,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,220,000,000Source | 4,171,000,000Source | 1,608,000,000Source | 1,142,000,000Source |
| Liabilities and EquityUSD | 29,677,000,000Source | 28,936,000,000Source | 28,312,000,000Source | 27,156,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,463,000,000Source | 4,310,000,000Source | 4,760,000,000Source | 4,476,000,000Source |
| Operating Lease, Liability, CurrentUSD | 214,000,000Source | 204,000,000Source | 204,000,000Source | 207,000,000Source |
| Accounts Payable, CurrentUSD | 1,360,000,000Source | 1,294,000,000Source | 1,408,000,000Source | 1,504,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,043,000,000Source | 950,000,000Source | 1,007,000,000Source | 1,046,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 240,000,000Source | 227,000,000Source | 326,000,000Source | 217,000,000Source |
| Other Liabilities, NoncurrentUSD | 1,713,000,000Source | 1,573,000,000Source | 1,709,000,000Source | 1,787,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,797,000,000Source | 1,649,000,000Source | 1,509,000,000Source | 1,317,000,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 1,226,000,000Source | 1,144,000,000Source | 1,169,000,000Source | 1,186,000,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 2,956,000,000Source | 2,727,000,000Source | 2,391,000,000Source | 2,149,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 2,367,000,000Source | 4,064,000,000Source | 1,311,000,000Source | 1,001,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 863,000,000Source | 818,000,000Source | 870,000,000Source | 841,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 104,000,000Source | 67,000,000Source | 66,000,000Source | 56,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -20,000,000Source | -245,000,000Source | 29,000,000Source | 140,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | 9,000,000Source | -103,000,000Source | 52,000,000Source | 209,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 3,540,000,000Source | 2,047,000,000Source | 2,374,000,000Source | 1,083,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 308,000,000Source | 571,000,000Source | 224,000,000Source | 234,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,275,000,000Source | 3,429,000,000Source | -969,000,000Source | -808,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -2,000,000Source | 19,000,000Source | 11,000,000Source | 6,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,010,000,000Source | 931,000,000Source | 751,000,000Source | 762,000,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 51,000,000Source | — | — | — |
| Payments for Repurchase of Common StockUSD | 1,386,000,000Source | 672,000,000Source | 200,000,000Source | 250,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -2,401,000,000Source | -3,685,000,000Source | -1,035,000,000Source | -1,781,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 55,000,000Source | 33,000,000Source | 71,000,000Source | -46,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -136,000,000Source | 1,791,000,000Source | 370,000,000Source | -1,506,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,883,000,000Source | 3,019,000,000Source | 1,228,000,000Source | 858,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 865,000,000Source | 851,000,000Source | 882,000,000Source | 848,000,000Source |
| Income Taxes Paid, NetUSD | 450,000,000Source | 1,271,000,000Source | 243,000,000Source | 161,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 104,000,000Source | 67,000,000Source | 66,000,000Source | 56,000,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 23,000,000Source | 26,000,000Source | 32,000,000Source | 33,000,000Source |
| Amortization of Intangible AssetsUSD | 166,000,000Source | 172,000,000Source | 174,000,000Source | 172,000,000Source |
| Deferred Other Tax Expense (Benefit)USD | 9,000,000Source | -103,000,000Source | 52,000,000Source | 209,000,000Source |
| DepreciationUSD | 697,000,000Source | 646,000,000Source | 696,000,000Source | 669,000,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 4,000,000Source | 4,000,000Source | 29,000,000Source | 117,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | -64,000,000Source | -35,000,000Source | -47,000,000Source | -70,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | -4,000,000Source | -8,000,000Source | -11,000,000Source | -109,000,000Source |
| GoodwillUSD | 11,198,000,000Source | 10,691,000,000Source | 10,307,000,000Source | 10,123,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 1,407,000,000Source | 3,200,000,000Source | 611,000,000Source | 410,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,311,000,000Source | 1,000,000,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | 1,000,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 1,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 264,000,000Source | 260,000,000Source | 228,000,000Source | 216,000,000Source |
| Income (Loss) from Equity Method Investments, Net of Dividends or DistributionsUSD | 34,000,000Source | 29,000,000Source | 13,000,000Source | -2,000,000Source |
| Income Tax Expense (Benefit)USD | 433,000,000Source | 1,184,000,000Source | 306,000,000Source | 344,000,000Source |
| InterestExpenseNonoperatingUSD | 821,000,000Source | 826,000,000Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 960,000,000Source | 864,000,000Source | 700,000,000Source | 590,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,407,000,000Source | 3,200,000,000Source | 611,000,000Source | 411,000,000Source |
| Other Nonoperating Income (Expense)USD | 117,000,000Source | 126,000,000Source | 19,000,000Source | 10,000,000Source |
| Payments to Acquire InvestmentsUSD | 90,000,000Source | 94,000,000Source | 104,000,000Source | 92,000,000Source |
| Restructuring CostsUSD | 44,000,000Source | 56,000,000Source | 79,000,000Source | 118,000,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | 1,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 21,310,000,000Source | 20,665,000,000Source | 20,548,000,000Source | 19,174,000,000Source |
| Operating Income (Loss)USD | 3,508,000,000Source | 5,956,000,000Source | 2,510,000,000Source | 2,333,000,000Source |
| Other Nonoperating Income (Expense)USD | 117,000,000Source | 126,000,000Source | 19,000,000Source | 10,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 2,800,000,000Source | 5,248,000,000Source | 1,617,000,000Source | 1,344,000,000Source |
| Income Tax Expense (Benefit)USD | 433,000,000Source | 1,184,000,000Source | 306,000,000Source | 344,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 960,000,000Source | 864,000,000Source | 700,000,000Source | 590,000,000Source |
| Earnings Per Share, BasicUSD per share | 15.61Source | 33.02Source | 6.01Source | 3.84Source |
| Earnings Per Share, DilutedUSD per share | 15.49Source | 32.7Source | 5.71Source | 3.79Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 90,150,000Source | 96,904,000Source | 101,639,000Source | 106,929,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 90,833,000Source | 97,881,000Source | 104,800,000Source | 110,516,000Source |
| Interest Expense (non-operating)USD | 821,000,000Source | 826,000,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 166,000,000Source | 172,000,000Source | 174,000,000Source | 172,000,000Source |
| Business Combination, Acquisition Related CostsUSD | 25,000,000Source | 39,000,000Source | 15,000,000Source | 14,000,000Source |
| Current Income Tax Expense (Benefit)USD | 424,000,000Source | 1,287,000,000Source | 254,000,000Source | 135,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | -64,000,000Source | -35,000,000Source | -47,000,000Source | -70,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 1,407,000,000Source | 3,200,000,000Source | 611,000,000Source | 410,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 2,805,000,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,311,000,000Source | 1,000,000,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 15.61Source | 33.02Source | 6.01Source | 3.83Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 15.49Source | 32.7Source | 5.71Source | 3.78Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | 1,000,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 1,000,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 264,000,000Source | 260,000,000Source | 228,000,000Source | 216,000,000Source |
| Interest ExpenseUSD | — | — | 901,000,000Source | 890,000,000Source |
| Labor and Related ExpenseUSD | 8,705,000,000Source | 8,801,000,000Source | 9,146,000,000Source | 8,844,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,407,000,000Source | 3,200,000,000Source | 611,000,000Source | 411,000,000Source |
| Other Cost and Expense, OperatingUSD | 4,523,000,000Source | 4,492,000,000Source | 4,515,000,000Source | 3,998,000,000Source |
| Restructuring CostsUSD | 44,000,000Source | 56,000,000Source | 79,000,000Source | 118,000,000Source |
Filing attachments
d104323dex42.htm · 8-K · 2026-09-22
Exhibit 4.2 TENET HEALTHCARE CORPORATION Forty-Third Supplemental Indenture Dated as of September 22, 2026 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 6.250% Senior Notes Due 2034 TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION SECTION 1.1 …
Read attachment ↗thc-20260908ex991.htm · 8-K · 2026-09-08
EX-99.1 2 thc-20260908ex991.htm EX-99.1 Document Exhibit 99.1 Tenet Announces Private Offering of Senior Notes to Refinance $1.5 Billion in Outstanding Notes DALLAS - September 8, 2026 - Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.5 billion in aggregate principal amount of new senior notes due 2034 (the “notes”) to refinance $1.5 billion of its currently outstanding notes. Completion of the notes offering is subject to, among other things, p…
Read attachment ↗thc-20260908ex992.htm · 8-K · 2026-09-08
EX-99.2 3 thc-20260908ex992.htm EX-99.2 Document Exhibit 99.2 Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes DALLAS - September 8, 2026 - Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.0 billion in aggregate principal amount of senior notes due on September 15, 2034, which will bear interest at a rate of 6.250% per annum (the “notes”).…
Read attachment ↗d845102dex42.htm · 8-K · 2025-11-18
EX-4.2 2 d845102dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 Execution Version TENET HEALTHCARE CORPORATION AND THE GUARANTORS FROM TIME TO TIME PARTY HERETO Forty-First Supplemental Indenture Dated as of November 18, 2025 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 5.500% Senior Secured First Lien Notes Due 2032 TABLE OF CONTENTS …
Read attachment ↗d845102dex43.htm · 8-K · 2025-11-18
EX-4.3 3 d845102dex43.htm EX-4.3 EX-4.3 Exhibit 4.3 Execution Version TENET HEALTHCARE CORPORATION Forty-Second Supplemental Indenture Dated as of November 18, 2025 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 6.000% Senior Notes Due 2033 TABLE OF CONTENTS Page ARTICLE ONE DEFINITI…
Read attachment ↗